These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 25770663)
1. Bartter/Gitelman syndromes as a model to study systemic oxidative stress in humans. Maiolino G; Azzolini M; Rossi GP; Davis PA; Calò LA Free Radic Biol Med; 2015 Nov; 88(Pt A):51-8. PubMed ID: 25770663 [TBL] [Abstract][Full Text] [Related]
2. Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling. Calò LA; Pagnin E; Davis PA; Sartori M; Semplicini A Nephrol Dial Transplant; 2003 Aug; 18(8):1518-25. PubMed ID: 12897089 [TBL] [Abstract][Full Text] [Related]
3. Calcitonin gene-related peptide, heme oxygenase-1, endothelial progenitor cells and nitric oxide-dependent vasodilation relationships in a human model of angiotensin II type-1 receptor antagonism. Calò LA; Davis PA; Pagnin E; Dal Maso L; Caielli P; Rossi GP J Hypertens; 2012 Jul; 30(7):1406-13. PubMed ID: 22573121 [TBL] [Abstract][Full Text] [Related]
4. Untangling the Uncertain Role of Overactivation of the Renin-Angiotensin-Aldosterone System with the Aging Process Based on Sodium Wasting Human Models. Thimm C; Adjaye J Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273282 [TBL] [Abstract][Full Text] [Related]
5. Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling. Calò LA; Facco M; Davis PA; Pagnin E; Maso LD; Puato M; Caielli P; Agostini C; Pessina AC Hypertens Res; 2011 Sep; 34(9):1017-22. PubMed ID: 21654754 [TBL] [Abstract][Full Text] [Related]
6. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved? Calò LA; Montisci R; Scognamiglio R; Davis PA; Pagnin E; Schiavo S; Mormino P; Semplicini A; Palatini P; D'Angelo A; Pessina AC J Endocrinol Invest; 2009 Nov; 32(10):832-6. PubMed ID: 19605975 [TBL] [Abstract][Full Text] [Related]
7. SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension. Davis PA; Pagnin E; Dal Maso L; Caielli P; Maiolino G; Fusaro M; Paolo Rossi G; Calò LA Hypertens Res; 2013 Oct; 36(10):873-8. PubMed ID: 23698802 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979 [TBL] [Abstract][Full Text] [Related]
9. The PGC1alpha-PPARdelta-HO-1 system: supporting evidence from studies in Bartter's/Gitelman's syndromes. Calò LA; Davis PA Cardiovasc Res; 2010 Jun; 86(3):535. PubMed ID: 20228397 [No Abstract] [Full Text] [Related]
10. Autonomic nervous system function in chronic hypotension associated with Bartter and Gitelman syndromes. Sartori M; Parotto E; Bonso E; Semplicini A; Palatini P; Pessina AC; Calò LA Am J Kidney Dis; 2007 Feb; 49(2):330-5. PubMed ID: 17261437 [TBL] [Abstract][Full Text] [Related]
11. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways. Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension. Ravarotto V; Pagnin E; Fragasso A; Maiolino G; Calò LA High Blood Press Cardiovasc Prev; 2015 Sep; 22(3):215-23. PubMed ID: 25759028 [TBL] [Abstract][Full Text] [Related]
13. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes. Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of reactive oxygen species in hypothalamic paraventricular nucleus attenuates the renin-angiotensin system and proinflammatory cytokines in hypertension. Su Q; Qin DN; Wang FX; Ren J; Li HB; Zhang M; Yang Q; Miao YW; Yu XJ; Qi J; Zhu Z; Zhu GQ; Kang YM Toxicol Appl Pharmacol; 2014 Apr; 276(2):115-20. PubMed ID: 24576725 [TBL] [Abstract][Full Text] [Related]
15. Linking inflammation and hypertension in humans: studies in Bartter's/Gitelman's syndrome patients. Caló LA; Davis PA; Pagnin E; Schiavo S; Semplicini A; Pessina AC J Hum Hypertens; 2008 Mar; 22(3):223-5. PubMed ID: 18046435 [No Abstract] [Full Text] [Related]
16. Number and function of circulating endothelial progenitor cells and calcitonin gene-related peptide in hypertension: support from and opportunities in Bartter's and Gitelman's syndromes patients. Calò LA; Davis PA J Hypertens; 2010 Oct; 28(10):2169-70; author reply 2171. PubMed ID: 20844372 [No Abstract] [Full Text] [Related]
17. Does Bartter's syndrome/Gitelman's syndrome provide a clinical model for investigating the association between calcitonin gene-related peptide and angiotensin II-mediated senescence of endothelial progenitor cells? Tura O; Mills NL; Hadoke PW J Hypertens; 2010 Oct; 28(10):2170-1; author reply 2171. PubMed ID: 20844373 [No Abstract] [Full Text] [Related]
18. Different roles of the RAAS affect bone metabolism in patients with primary aldosteronism, Gitelman syndrome and Bartter syndrome. Tang W; Chai Y; Jia H; Wang B; Liu T; Wang H; Dai C BMC Endocr Disord; 2022 Feb; 22(1):38. PubMed ID: 35148746 [TBL] [Abstract][Full Text] [Related]